Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 4361 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Anavex Life Sciences Corp.

Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Venus Concept Inc.

Hydreight Partners with American Frontline Nurses with a Network of Over 26,000 Nurses

Read more ››
By: GlobeNewswire - 25 Mar 2024

SIGA Names Larry Miller General Counsel

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  SIGA Technologies, Inc.

Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Allarity Therapeutics, Inc.

MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry

Read more ››
By: GlobeNewswire - 25 Mar 2024

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 25 Mar 2024

GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare

Read more ››
By: GlobeNewswire - 25 Mar 2024

Bluejay Announces Receipt of PRIME Designation from European Medicines Agency (EMA) for BJT-778 for the Treatment of Chronic Hepatitis Delta Virus Infection

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Bluejay Therapeutics Inc.

One World Products, Inc. Secures Exclusive Rights With Procepack for State-of-the-Art PreRoll-Er Equipment in Colombia

Read more ››
By: GlobeNewswire - 25 Mar 2024

Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Plus Therapeutics, Inc.

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Artelo Biosciences, Inc.

Starton Therapeutics to Present at Upcoming MedInvest and Needham Conferences

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Starton Therapeutics Inc.

Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Ardelyx, Inc

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Tonix Pharmaceuticals Holding Corp.

NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  NewAmsterdam Pharma B.V.

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Daxor Corporation

Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Matinas BioPharma Holdings Inc.

Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Rhythm Pharmaceuticals, Inc.

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Amarin Corporation plc
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑